​

Madrigal Pharmaceuticals Ownership | Who Owns Madrigal Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Madrigal Pharmaceuticals Ownership Summary

Madrigal Pharmaceuticals is owned by 10.83% institutional investors, 7.70% insiders, and 81.47% retail investors. Janus henderson group is the largest institutional shareholder, holding 10.16% of MDGL shares. Janus Concentrated Growth CF is the top mutual fund, with 2.72% of its assets in Madrigal Pharmaceuticals shares.

MDGL Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockMadrigal Pharmaceuticals10.83%7.70%81.47%
SectorHealthcare Stocks 232.51%10.72%-143.23%
IndustryBiotech Stocks 384.56%10.58%-295.14%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Janus henderson group2.21M10.16%$681.37M
Baker bros. advisors lp2.14M9.64%$982.31M
Rtw investments, lp1.99M8.98%$914.42M
Paulson1.91M8.59%$874.90M
Avoro capital advisors1.83M8.25%$840.72M
Vanguard group1.81M8.05%$1.05B
Blackrock funding, inc. /de1.64M7.32%$957.80M
Blackrock1.43M7.14%$399.86M
State street658.10K2.96%$301.84M
Geode capital management451.74K2.01%$263.11M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Paulson1.91M29.46%$874.90M
Tao capital management lp41.00K14.22%$18.81M
Rtw investments, lp1.99M11.27%$914.42M
Avoro capital advisors1.83M10.87%$840.72M
Nan fung group11.87K9.13%$5.45M
Ally bridge group (ny)32.66K9.12%$14.98M
Bioimpact capital100.42K7.54%$46.06M
Tri locum partners lp67.71K7.14%$31.05M
Baker bros. advisors lp2.14M7.10%$982.31M
Affinity asset advisors115.00K4.59%$52.75M

Top Buyers

HolderShares% AssetsChange
Wellington management group llp404.45K0.03%397.08K
Blackrock1.43M0.01%216.86K
Norges bank196.39K0.01%196.39K
Baker bros. advisors lp2.14M7.10%165.68K
Deutsche bank ag\192.11K0.04%154.77K

Top Sellers

HolderShares% AssetsChange
Holocene advisors, lp---390.55K
Adage capital partners gp88.50K0.06%-287.66K
Janus henderson group2.21M0.35%-269.77K
Ra capital management---204.50K
Bain capital life sciences investors---197.00K

New Positions

HolderShares% AssetsChangeValue
Norges bank196.39K0.01%196.39K$114.37M
Alkeon capital management120.00K0.08%120.00K$55.04M
Driehaus capital management115.97K0.38%115.97K$53.19M
Iron triangle partners lp58.38K3.81%58.38K$26.78M
Ally bridge group (ny)32.66K9.12%32.66K$14.98M

Sold Out

HolderChange
Atlas capital advisors-1.00
Fifth third bancorp-1.00
True wealth design-1.00
Ronald blue trust-1.00
Cva family office-2.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025121-68.24%2,435,684-89.59%100.10%55-72.36%40-61.90%
Sep 30, 2025135-57.68%3,008,956-86.78%130.13%69-51.75%40-63.64%
Jun 30, 2025325-4.69%23,563,8530.96%1060.95%144-20.00%11118.09%
Mar 31, 20253416.90%23,616,0522.83%1060.96%1784.09%9626.32%
Dec 31, 20243005.63%19,963,834-11.66%910.85%15720.77%75-14.77%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Janus Concentrated Growth CF604.92K2.72%-27.38K
Janus Henderson Forty S604.92K2.72%-
Vanguard Total Stock Mkt Idx Inv598.65K2.69%-12.61K
Vanguard US Total Market Shares ETF578.31K2.62%388.00
Vanguard Small Cap Index458.31K2.06%-2.70K
iShares Russell 2000 ETF407.25K1.83%-
Janus Henderson Opportunistic Alpha MA319.65K1.47%319.62K
Janus Henderson US Opportunistic Alpha304.98K1.37%-52.93K
Janus Henderson Contrarian D304.98K1.37%-
SPDR® S&P Biotech ETF299.46K1.34%670.00

Recent Insider Transactions

DateNameRoleActivityValue
Jan 26, 2026Huntsman Carole Chief Commercial OfficerSell$167.42K
Jan 26, 2026Huntsman Carole Chief Commercial OfficerSell$281.92K
Jan 26, 2026Sibold William John President and CEOSell$776.55K
Jan 26, 2026Taub Rebecca-Sell$318.60K
Jan 20, 2026Kelley Shannon T General CounselSell$129.07K

Insider Transactions Trends

DateBuySell
2026 Q1-66
2025 Q4-70
2025 Q35478
2025 Q2--
2025 Q1-56

MDGL Ownership FAQ

Who Owns Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals shareholders are primarily institutional investors at 10.83%, followed by 7.70% insiders and 81.47% retail investors. The average institutional ownership in Madrigal Pharmaceuticals's industry, Biotech Stocks , is 384.56%, which Madrigal Pharmaceuticals falls below.

Who owns the most shares of Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals’s largest shareholders are Janus henderson group (2.21M shares, 10.16%), Baker bros. advisors lp (2.14M shares, 9.64%), and Rtw investments, lp (1.99M shares, 8.98%). Together, they hold 28.78% of Madrigal Pharmaceuticals’s total shares outstanding.

Does Blackrock own Madrigal Pharmaceuticals?

Yes, BlackRock owns 7.14% of Madrigal Pharmaceuticals, totaling 1.43M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 399.86M$. In the last quarter, BlackRock increased its holdings by 216.86K shares, a 17.92% change.

Who is Madrigal Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Paulson is Madrigal Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 29.46% of its assets in 1.91M Madrigal Pharmaceuticals shares, valued at 874.9M$.

Who is the top mutual fund holder of Madrigal Pharmaceuticals shares?

Janus Concentrated Growth CF is the top mutual fund holder of Madrigal Pharmaceuticals shares, with 2.72% of its total shares outstanding invested in 604.92K Madrigal Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools